Lead Edge Capital Management’s Yext YEXT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.1M Sell
7,843,296
-4,948,782
-39% -$29.8M 7.38% 8
2025
Q4
$103M Hold
12,792,078
26.44% 1
2025
Q3
$109M Hold
12,792,078
28.8% 1
2025
Q2
$109M Hold
12,792,078
30.1% 1
2025
Q1
$78.8M Hold
12,792,078
23.93% 1
2024
Q4
$81.4M Hold
12,792,078
27.52% 1
2024
Q3
$88.5M Buy
12,792,078
+1,317,797
+11% +$7.33M 25.63% 1
2024
Q2
$61.4M Hold
11,474,281
19.59% 2
2024
Q1
$69.2M Hold
11,474,281
21.27% 1
2023
Q4
$67.6M Hold
11,474,281
18.06% 1
2023
Q3
$72.6M Hold
11,474,281
25.79% 1
2023
Q2
$130M Hold
11,474,281
39.92% 1
2023
Q1
$110M Hold
11,474,281
34.64% 1
2022
Q4
$74.9M Hold
11,474,281
25.91% 1
2022
Q3
$51.2M Buy
11,474,281
+2,548,000
+29% +$11.8M 21.28% 3
2022
Q2
$42.7M Buy
8,926,281
+1,952,281
+28% +$10.8M 11.84% 4
2022
Q1
$48.1M Buy
+6,974,000
New +$53.2M 10.52% 3

Other funds holding YEXT

Lead Edge Capital Management's YEXT Position: Q1 2026 in Review

Lead Edge Capital Management reduced its Yext (YEXT) stake by 39% in Q1 2026, selling an estimated $29.8M and leaving 7,843,296 shares worth $30.1M. The position accounts for 7.38% of the portfolio, ranked #8.

Lead Edge Capital Management first reported a position in YEXT in Q1 2022 and has held it in 17 quarters since. The position peaked at $130M in Q2 2023. 200 funds tracked by Wall St. Rank hold YEXT as of Q1 2026.

  • Lead Edge Capital Management held 7,843,296 shares of Yext worth $30.1M as of Q1 2026.
  • Lead Edge Capital Management sold 4,948,782 Yext shares in Q1 2026, an estimated $29.8M.
  • Yext made up 7.38% of Lead Edge Capital Management's portfolio in Q1 2026, its #8 holding.
  • Lead Edge Capital Management first reported a position in Yext in Q1 2022 and has held it in 17 quarters since.
  • Lead Edge Capital Management's Yext position peaked at $130M in Q2 2023.
  • 200 funds tracked by Wall St. Rank held Yext as of Q1 2026.

Based on Lead Edge Capital Management's 13F filing for Q1 2026, filed 15 May 2026.